echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Hospitals frequently report letters exposed rebates, rate of increase, sales interest chain ...

    Hospitals frequently report letters exposed rebates, rate of increase, sales interest chain ...

    • Last Update: 2020-11-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Hebei, Shandong, Anhui multi-dity hospitals frequently appear in the "report letter" recently, Anhui three hospitals posted a number of anonymous reporting letters.
    the contents of these letters are approximately the same.
    report letter pointed out that some of these hospital doctors and medical representatives have abnormal sales relations, there are problems with gold sales.
    The report involves varieties from three well-known domestic pharmaceutical companies, including narcotic drugs, oncology drugs, etc. , the amount of rebates to doctors accounted for about 12% of the drug price, but also in the name of the conference to pay doctors lecture fees.
    of the report indicates the drug involved, and some report letters give the amount or proportion of the rebate.
    that there is an abnormal sales relationship between doctors and pharmaceutical representatives, there are problems with gold sales.
    report letter involving sections and kickbacks" ... The production of anti-tumor drugs, retail price of 3409 yuan a box, cancer patients a month treatment costs 10227 yuan, the hospital oncologist, radiotherapy doctors actually take 400 rebates per box..." Oncology and radiotherapy department output from August 2018 to date, a total of more than 750 boxes, bribes up to more than 300,000.
    "" Jiangsu... Limited Companies in the hospital has imaging-related drugs, narcotics-related drugs, infection-related varieties, respiratory drugs, hematology drugs, oncology radiotherapy drugs, etc., each selling a box of drugs, to prescription doctors drug prices 12% cash..." Report letter exposure rate agent exposure terminal product marketing policy and business commission rate: report letter revealed with gold sales interest chain ... Pharmaceutical group sales companies in the market, to its agents and market sales staff, take the product floor price and high rates, and instigate sales staff to medical institutions to promote the sale of gold, commercial bribery, in order to achieve sales performance, task indicators, take a series of illegal means across the compliance bottom line, with some medical personnel to form a black chain of interests Covering a number of departments, such as public relations to doctors, the implementation of bribery, kickbacks and other promotional means, so that doctors more prescriptions, indiscriminate prescriptions..." Many hospitals frequently appear to report letters, and the current drug market white hot competition has an inextricable relationship, in the growing performance pressure and conflict of interest, whistleblowing letters have burst out.
    generally speaking, the pharmaceutical industry's reporting is mainly divided into several situations, if the whistleblower is a pharmaceutical practitioner, the report may be for the following purposes: 1, to blackmail the hospital side for profit.
    hospital doctors or leaders received the corresponding benefits, but did not meet the needs of pharmaceutical representatives or enterprises;
    competition between pharmaceutical companies but competitors, then retaliate; 3, out of public welfare psychology, want to trigger the relevant departments to follow up on the management of commercial bribery.
    4, hospital insiders are unhappy and report.
    hospital is also a workplace, in this environment there is also a conflict between the distribution of benefits and colleagues, sometimes, some departments, in the internal distribution of benefits, there may be people because of dissatisfaction and choose to report.
    For whatever reason, compliance pressures are soaring across the pharmaceutical industry, and at this sensitive time, the letter appears to be at the right time, allowing gold sales to raise as much attention as possible and expanding the impact of medical corruption.
    recently, the National Health and Safety Commission, the Central Commission for Discipline Inspection and other departments have issued a number of documents to rectify the pharmaceutical supplies enterprise rebate behavior.
    September 2, the official website of the Central Commission for Discipline Inspection published the article "Taking cases as a guide, Chengdu seriously rectifying corruption in the medical field", referring directly to medical personnel receiving red envelope gifts from management objects, using the convenience of their positions, and adopting illegal methods for relevant personnel in drug supply, equipment procurement for profit and other illegal and disciplinary acts.
    July 24, the National Health and Safety Commission issued a "notice on the issuance of the 2020 medical industry style construction work special action plan", clearly from July this year until the end of the year, will focus on the treatment of medical personnel to collect kickbacks, pharmaceutical companies illegal marketing and other acts.
    June 5, the National Health and Wellness Commission and nine other departments jointly issued "2020 to correct the field of pharmaceutical purchase and sale and medical services in the field of the wrong wind work points", clear and serious investigation and punishment of the collection of pharmaceutical supplies enterprise rebate behavior.
    Hospital inspection high-pressure period, sword refers to medical corruption August 25, the National Health and Health Commission held inspection work meeting and the party group 2020 inspection mobilization deployment meeting, inspection team members list, the list of inspected party organizations and inspection tasks arranged out, announced that the hospital inspection into the high-pressure period.
    September 1, the Shanghai Municipal People's Government issued the Shanghai Public Hospital Inspection Implementation Plan (2020-2022), in which it stated that the Shanghai Municipal Health and Health Commission has formulated the Shanghai Public Hospital Inspection Implementation Plan (2020-2). 2022), will be the city-wide public hospitals at the second and third levels, the third-level hospitals, the second-level A general hospital, the second-level Chinese medicine hospital (including Chinese and Western medicine combined hospitals), the second-level B general hospital, the second-level specialized hospitals to carry out inspection work.
    overseas, Beijing, Liaoning, Shandong, Hebei and other places have also issued relevant documents, announced the jurisdiction of medical institutions to carry out verification.
    With the advance of national procurement, the development of tax verification in the pharmaceutical industry, as well as under the two-vote system, health insurance fee control policy, coupled with a strict investigation of drug rebates, crack down on medical corruption, the traditional drug marketing methods that used to rely on high drug pricing and channel space to drive sales will be completely subverted.
    high-pressure market environment and huge conflicts of interest, the pharmaceutical industry will be full of whistle-blowing letters, pharmaceutical companies must be timely transformation.
    attached to the report letter posted at the hospital:
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.